Effective delegation within the research team is also vital. Licensed medical assistants (MAs) play a critical role by ...

In today's ACT Brief, we examine HHS coordinated effort to restore US clinical research leadership, two decades of rising ...

The use of Artificial Intelligence (AI) and Machine Learning (ML) in clinical research is rapidly evolving, offering a glimpse into a future where medical innovation is driven by data-driven ...

The US Food and Drug Administration (FDA) is seeking comments on a pilot program where qualified external institutions will ...

The flowchart and steps below outlines the best practice for processing industry-written and sponsored clinical trials at UAB. There are many small steps in each of the larger defined steps (see flow ...

New guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents ...

GREENVILLE, S.C.--(BUSINESS WIRE)--Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...

NEW YORK & SALT LAKE CITY--(BUSINESS WIRE)--Protocol First, a software solutions provider focused on accelerating clinical research, has joined Flatiron Health Ⓡ as a wholly owned subsidiary, the two ...

Opioid Prescription Trends Among Patients With Cancer Referred to Outpatient Palliative Care Over a 6-Year Period We analyzed oncology clinical trials that underwent full board review by the Harold C.

Concern about publication bias has led to an emphasis on the need to report the results of all clinical trials, even those that end early with inconclusive results at the end of an outbreak. This ...